Sign up to save your podcasts
Or
Share Little Pharma On The Rise
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Little Pharma On The Rise
Concert Pharmaceuticals’ stock rises 80% on a deal with Vertex. Jason Moser analyzes the pharmaceutical landscape and weighs in on The New York Times’ new Twitter strategy. Plus we dip into the Fool Mailbag and share memories of the late Paul Kangas.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Concert Pharmaceuticals’ stock rises 80% on a deal with Vertex. Jason Moser analyzes the pharmaceutical landscape and weighs in on The New York Times’ new Twitter strategy. Plus we dip into the Fool Mailbag and share memories of the late Paul Kangas.
More shows like MarketFoolery
View all
Motley Fool Hidden Gems Investing
3,217 Listeners
InvestTalk
1,482 Listeners
Motley Fool Answers
808 Listeners
Rule Breaker Investing
944 Listeners
Investing Insights
521 Listeners
Bloomberg Surveillance
1,170 Listeners
Masters in Business
2,201 Listeners
Industry Focus
825 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,422 Listeners
Wall Street Breakfast
1,038 Listeners
The Best One Yet
9,715 Listeners
Chit Chat Stocks
195 Listeners
Ready For Retirement
833 Listeners
The Canadian Investor
84 Listeners
Early Retirement - Financial Freedom (Investing, Tax Planning, Retirement Strategy, Personal Finance)
584 Listeners
The Psychology of Money with Morgan Housel
1,049 Listeners
Stock Market Today With IBD
56 Listeners